Netherlands:Rapid Developments in Modern Biotechnology are a Challenge for Risk Assessment

摘要

Due to developments in modern biotechnology, such as genome editing, synthetic biology and regulation of gene expression, many new applications are expected in the next ten years. For example, new forms of gene therapy, new substances produced by microorganisms, and plants that are better adapted for agriculture. The method that is currently used for the assessment of risks for humanhealth and the environment does not seem to be equipped for future developments, according to the findings of a report by the Dutch National Institute for Public Health and the Environment (RIVM).